• Chat
  • Dashboard
  • Daily Briefing
  • Discover
    • Feedback
    • Sign In
    Sign InSign Up

    Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen - CNBC

    AI Summary1 min read

    TL;DR

    Eli Lilly introduces a multi-dose KwikPen for Zepbound, offering a month's worth of obesity drug doses in one pen after FDA approval.

    Tags

    Eli LillyZepboundobesity drugmulti-dose penFDA approval
    1. Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen  CNBC
    2. Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen  Eli Lilly
    3. Eli Lilly’s Zepbound Gets FDA OK for Multi-Dose Pen  The Wall Street Journal
    4. Lilly adds multidose Zepbound pens to self-pay menu after FDA nod  Fierce Pharma
    5. Lilly to launch multi-dose weight-loss drug device in US  Yahoo Finance

    Monday, February 23, 2026 2:00 PM

    Visit Website
    website-logo

    Top stories - Google News

    Google News

    channel icon
    Related Articles

    Philadelphia snow updates: Snowfall totals; latest forecast; travel impact and more - WHYY

    Feb 23, 2026

    Study reveals whistling secret of horses’ whinny - The Guardian

    Feb 23, 2026

    European Support for Ukraine Stumbles on Eve of Invasion’s 4th Anniversary - The New York Times

    Feb 23, 2026

    Baftas 2026: BBC apologises for not editing out racial slur shouted by guest with Tourette's - BBC

    Feb 23, 2026
    xgithub
    logo

    Copyright © 2022-2026 - Aetos.AI